Zildox 50 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Oxaliplatin

Indications/Uses

Metastatic colorectal cancer in combination w/ 5-fluorouracil & folinic acid.

Click to view Zildox 50 detailed prescribing information

Dosage/Direction for Use

85 mg/m² IV infusion over 2-6 hr. Dose may be repeated at intervals of 2 wk. Adjuvant treatment: 65 mg/m² for 12 cycles.

Click to view Zildox 50 detailed prescribing information

Overdosage

View Zildox 50 overdosage for action to be taken in the event of an overdose.

Contraindications

History of known allergy or other platinum compd. Preexisting sensory neuropathies, myelosuppression, severe renal impairment.

Click to view Zildox 50 detailed prescribing information

Special Precautions

Pulmonary fibrosis; cough & dyspnea. Increased transaminases & alkaline phosphate. Avoid cold drinks, use of ice & cover exposed skin to cold temperatures or objects. Pregnancy.

Click to view Zildox 50 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Zildox 50 detailed prescribing information

Adverse Reactions

Peripheral sensory neuropathy, neutropenia, thrombocytopenia, anemia, nausea, increase transaminases & alkaline phosphatase, diarrhea, emesis, fatigue & stomatitis.

Click to view Zildox 50 detailed prescribing information

Drug Interactions

Increase plasma conc w/ 5-FU.

Click to view Zildox 50 detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Zildox 50 detailed prescribing information

Storage

View Zildox 50 storage conditions for details to ensure optimal shelf-life.

Description

View Zildox 50 description for details of the chemical structure and excipients (inactive components).

Action

View Zildox 50 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cytotoxic Chemotherapy

ATC Classification

L01XA03 - oxaliplatin ; Belongs to the class of platinum-containing antineoplastic agents. Used in the treatment of cancer.

Regulatory Classification

Patient Counseling Information

View Zildox 50 patient counselling information

Presentation/Packing

Form

Zildox 50 powd for IV infusion (lyo) 50 mg

Packing/Price

1's

Zildox 50

oxaliplatin

Manufacturer:

Naprod

Distributor:

Multicare

Marketer:

Multicare